NCT03278990 Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves Status TERMINATED Phase NA
NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 Status RECRUITING Phase N/A
NCT03251144 Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Status COMPLETED Phase PHASE1/PHASE2
NCT03248479 Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies Status TERMINATED Phase PHASE1
NCT03235154 A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic Status COMPLETED Phase PHASE4
NCT03231930 Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study Status COMPLETED Phase NA
NCT03219164 Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria Status TERMINATED Phase PHASE3
NCT03207815 Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis Status TERMINATED Phase PHASE2
NCT03201445 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease Status TERMINATED Phase PHASE2
NCT03195205 Identification to Elimination in HCV-Infected Individuals Status COMPLETED Phase EARLY_PHASE1
NCT03180619 Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) Status COMPLETED Phase PHASE2
NCT03158116 The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas Status TERMINATED Phase PHASE4
NCT03155802 Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines Status UNKNOWN Phase N/A
NCT03151057 Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies Status TERMINATED Phase PHASE1
NCT03135028 Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults Status TERMINATED Phase PHASE1
NCT03134222 Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) Status COMPLETED Phase PHASE2
NCT03133221 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT03121235 PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. Status COMPLETED Phase N/A